Homegrown perceptions about the medical use and potential abuse of CBD and THC.

. 2020 Dec 24;115:106799.
doi: 10.1016/j.addbeh.2020.106799. Online ahead of print.
Affiliations
Item in Clipboard
Addict Behav. .
Abstract
Despite heightened consumer interest in cannabinoids such as cannabidiol (CBD) and tetrahydrocannabinol (THC), little is known about public perceptions regarding their medical use and potential for abuse, particularly relative to commonly used medications. Using data from 1,050 U.S. adult respondents from a national survey conducted in 2019, this study found that more than half of respondents perceived CBD, THC, hemp, and marijuana as having medical use. They also perceived the potential for abuse of CBD, THC, hemp, and marijuana as significantly less than potential for abuse of commonly prescribed anti-anxiety and pain medications. At the nexus of medical use and potential abuse, public perceptions classified CBD and hemp as similar to over-the-counter pain relief medications such as Advil and Tylenol and did not classify marijuana as a Schedule I substance. Slightly more than 20% of respondents reported having consumed CBD and/or THC. CBD was consumed more than THC to reduce pain while THC was consumed more than CBD for recreation. There were no differences in the types of medications they were replacing with CBD and THC.
Keywords: Cannabinoids; Cannabis; Drug scheduling; Medication replacement.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
The Impact of Cannabidiol on Psychiatric and Medical Conditions.
J Clin Med Res. 2020 Jul;12(7):393-403. doi: 10.14740/jocmr4159. Epub 2020 Jun 25. J Clin Med Res. 2020. PMID: 32655732 Free PMC article. Review.
-
Are side effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?
F1000Res. 2019 Aug 8;8:1394. doi: 10.12688/f1000research.19931.3. eCollection 2019. F1000Res. 2019. PMID: 32117565 Free PMC article.
-
A preliminary investigation of lung availability of cannabinoids by smoking marijuana or dabbing BHO and decarboxylation rate of THC- and CBD-acids.
Forensic Sci Int. 2019 Feb;295:207-212. doi: 10.1016/j.forsciint.2018.12.021. Epub 2019 Jan 6. Forensic Sci Int. 2019. PMID: 30638755
-
Concentrations of THC, CBD, and CBN in commercial hemp seeds and hempseed oil sold in Korea.
Forensic Sci Int. 2020 Jan;306:110064. doi: 10.1016/j.forsciint.2019.110064. Epub 2019 Nov 15. Forensic Sci Int. 2020. PMID: 31786513
-
Clinicians’ Guide to Cannabidiol and Hemp Oils.
Mayo Clin Proc. 2019 Sep;94(9):1840-1851. doi: 10.1016/j.mayocp.2019.01.003. Epub 2019 Aug 22. Mayo Clin Proc. 2019. PMID: 31447137 Review.